🏅 FDA Orphan Designation
Vykat Xr
DIAZOXIDE CHOLINE
Manufacturer: Soleno Therapeutics, Inc.
Indicated for:
Prader-Willi syndromeOrphan
FDA-Approved Indications (1)
Prader-Willi syndromeOrphan Designation
treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome (PWS)
Indications & Usage
1 INDICATIONS AND USAGE VYKAT XR is indicated for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome (PWS). VYKAT XR is indicated for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome (PWS). ( 1 )
💙 Support Programs
View all →VYKAT XR
AstraZeneca
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.